Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Negative regulation of toll-like receptor-mediated signaling by Tollip.

Zhang G, Ghosh S.

J Biol Chem. 2002 Mar 1;277(9):7059-65. Epub 2001 Dec 18.

3.

A central role for the Hsp90.Cdc37 molecular chaperone module in interleukin-1 receptor-associated-kinase-dependent signaling by toll-like receptors.

De Nardo D, Masendycz P, Ho S, Cross M, Fleetwood AJ, Reynolds EC, Hamilton JA, Scholz GM.

J Biol Chem. 2005 Mar 18;280(11):9813-22. Epub 2005 Jan 12.

4.

Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.

Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies CA, Mansell AS, Brady G, Brint E, Dunne A, Gray P, Harte MT, McMurray D, Smith DE, Sims JE, Bird TA, O'Neill LA.

Nature. 2001 Sep 6;413(6851):78-83.

PMID:
11544529
5.

Mechanisms of cross hyporesponsiveness to Toll-like receptor bacterial ligands in intestinal epithelial cells.

Otte JM, Cario E, Podolsky DK.

Gastroenterology. 2004 Apr;126(4):1054-70.

PMID:
15057745
6.

Summary and comparison of the signaling mechanisms of the Toll/interleukin-1 receptor family.

Martin MU, Wesche H.

Biochim Biophys Acta. 2002 Nov 11;1592(3):265-80. Review.

7.

SIGIRR inhibits interleukin-1 receptor- and toll-like receptor 4-mediated signaling through different mechanisms.

Qin J, Qian Y, Yao J, Grace C, Li X.

J Biol Chem. 2005 Jul 1;280(26):25233-41. Epub 2005 May 2.

9.
10.

Structural complementarity of Toll/interleukin-1 receptor domains in Toll-like receptors and the adaptors Mal and MyD88.

Dunne A, Ejdeback M, Ludidi PL, O'Neill LA, Gay NJ.

J Biol Chem. 2003 Oct 17;278(42):41443-51. Epub 2003 Jul 29.

11.

Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor.

Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, Maschera B, Lewis A, Ray K, Tschopp J, Volpe F.

Nat Cell Biol. 2000 Jun;2(6):346-51.

PMID:
10854325
12.

Sequential autophosphorylation steps in the interleukin-1 receptor-associated kinase-1 regulate its availability as an adapter in interleukin-1 signaling.

Kollewe C, Mackensen AC, Neumann D, Knop J, Cao P, Li S, Wesche H, Martin MU.

J Biol Chem. 2004 Feb 13;279(7):5227-36. Epub 2003 Nov 18.

13.

Signaling events induced by lipopolysaccharide-activated toll-like receptor 2.

Yang RB, Mark MR, Gurney AL, Godowski PJ.

J Immunol. 1999 Jul 15;163(2):639-43.

14.
15.

Toll-like receptor-mediated tyrosine phosphorylation of paxillin via MyD88-dependent and -independent pathways.

Hazeki K, Masuda N, Funami K, Sukenobu N, Matsumoto M, Akira S, Takeda K, Seya T, Hazeki O.

Eur J Immunol. 2003 Mar;33(3):740-7.

16.

Regulation of IL-1 receptor-associated kinases by lipopolysaccharide.

Hu J, Jacinto R, McCall C, Li L.

J Immunol. 2002 Apr 15;168(8):3910-4.

17.

Severe impairment of interleukin-1 and Toll-like receptor signalling in mice lacking IRAK-4.

Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, Mirtsos C, Takada H, Wakeham A, Itie A, Li S, Penninger JM, Wesche H, Ohashi PS, Mak TW, Yeh WC.

Nature. 2002 Apr 18;416(6882):750-6. Epub 2002 Mar 31.

PMID:
11923871
18.

Phosphoinositide 3 kinase mediates Toll-like receptor 4-induced activation of NF-kappa B in endothelial cells.

Li X, Tupper JC, Bannerman DD, Winn RK, Rhodes CJ, Harlan JM.

Infect Immun. 2003 Aug;71(8):4414-20.

19.

Lipopolysaccharide rapidly traffics to and from the Golgi apparatus with the toll-like receptor 4-MD-2-CD14 complex in a process that is distinct from the initiation of signal transduction.

Latz E, Visintin A, Lien E, Fitzgerald KA, Monks BG, Kurt-Jones EA, Golenbock DT, Espevik T.

J Biol Chem. 2002 Dec 6;277(49):47834-43. Epub 2002 Sep 24.

20.

Human intestinal epithelial cells are broadly unresponsive to Toll-like receptor 2-dependent bacterial ligands: implications for host-microbial interactions in the gut.

Melmed G, Thomas LS, Lee N, Tesfay SY, Lukasek K, Michelsen KS, Zhou Y, Hu B, Arditi M, Abreu MT.

J Immunol. 2003 Feb 1;170(3):1406-15.

Supplemental Content

Support Center